Vitro Biopharma, Inc.
VTRO
Revenue
319.91k
▼-253.03k▼-44.16%
3 Months ChangeAssets
6.81M
▼-287.52k▼-4.05%
3 Months ChangeLiabilities
14.13M
▼-521.87k▼-3.56%
3 Months ChangeFree Cash Flow
-761.89k
▼-721.64k▼-1792.84%
96 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-09-16
Form 10-Q
ID: 0001493152-24-036326
2024-07-22
Form 8-K
ID: 0001493152-24-028669
2024-06-27
Form 8-K
ID: 0001493152-24-025334
2024-05-31
Form 10-Q
ID: 0001493152-24-022030
2024-05-17
Form 8-K
ID: 0001493152-24-020410
2024-04-17
Form 8-K
ID: 0001493152-24-015061
2024-03-14
Form 10-Q
ID: 0001493152-24-009929
2024-01-23
Form 8-K
ID: 0001493152-24-003346
2024-01-16
Form 8-K
ID: 0001493152-24-002272
2023-11-22
Form 8-K
ID: 0001493152-23-042449